Abstract: Embodiments are directed towards providing video game gameplay incorporating falling puzzle mechanics influenced by character movements within a puzzle space. In a preferred embodiment, a computer implemented method renders a game world that includes a puzzle space wherein a sequence of falling items aggregate in a puzzle formation. Players move characters within the puzzle space to remove items by colliding with them in an attempt to resolve the puzzle by clearing all items from the puzzle space. In one possible arrangement, the sequence of falling items is released according to character movements within the puzzle space. The relationship between character movements and falling puzzle items makes the game play more engaging by providing additional strategic and competitive elements to traditional falling puzzle games.

Abstract: The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.

Abstract: Disclosed herein are methods for treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy.

Abstract: This invention relates to methods of treating age-related macular degeneration (AMD). In particular, this invention provides methods of treating all forms of wet, age-related macular degeneration. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat wet AMD.

Abstract: This invention relates to methods of treating ocular disease. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat such disease.

Abstract: To package an application and a component to be available for use in connection with the application into a package, a type of the package and a location where the package is to be stored are received, as is a selection of the component to be packaged with the application. For the selected component, at least one packaging-specific object in such component is referred to to determine information on how to package the component in the package and/or how to install the component on the computing device of the user.

Abstract: This invention relates to methods of treating age-related macular degeneration (AMD). In particular, this invention provides methods of treating all forms of wet, age-related macular degeneration. The method of the invention is directed to the administration of an anti-vascular endothelial growth factor (anti-VEGF) compound to treat wet AMD.

Abstract: The present invention provides novel plant DNA sequences coding for native adenylosuccinate lyase (ADSL). Methods for using the complete or partial ADSL coding sequence as a probe for diagnostic, mapping and other purposes are taught. Generation of transformed host cells capable of expressing ADSL is also taught. Methods of using the transformed host cells are taught, including methods for recombinant production of ADSL enzymes. A method for using the plant ADSL enzyme to screen for inhibitors of ADSL activity is also provided.